Yokoyama, Keitaro
Shimazaki, Ryutaro
Fukagawa, Masafumi
Akizawa, Tadao
Maeda, Yoshitaka
Ueki, Kazue
Fujii, Takayuki
Miyazaki, Ryoichi
Azekura, Hisanori
Kasuga, Hirotake
Tomiyoshi, Yoshiyuki
Shinzato, Takeaki
Iwashita, Ryuji
Takada, Kenji
Suda, Akio
Nagaoka, Takashi
Yoshimoto, Mitsuru
Taniguchi, Masatomo
Ogawa, Hiroshi
,
Article History
Received: 17 July 2018
Accepted: 22 March 2019
First Online: 23 April 2019
Competing Interests
: This study and preparation of the manuscript was sponsored by Kyowa Hakko Kirin Co., Ltd. K.Y. received consulting fees and lecture fees from Kyowa Hakko Kirin Co., Ltd., Ono Pharmaceutical Co., Ltd. and Torii Pharmaceutical Co., Ltd. M.F. has received consulting fees from Kyowa Hakko Kirin Co., Ltd. and Ono Pharmaceutical Co., Ltd., and lecture fees from Kyowa Hakko Kirin Co., Ltd., Bayer Yakuhin, Ltd., Torii Pharmaceutical Co., Ltd. and Ono Pharmaceutical Co., Ltd., and grants from Kyowa Hakko Kirin Co., Ltd. and Bayer Yakuhin, Ltd. T.A. has received consulting fees from Kyowa Hakko Kirin Co., Ltd., Astellas Pharma Inc., Bayer Yakuhin, Ltd., Fuso Pharmaceutical Industries, Ltd., Japan Tobacco Inc., Ono Pharmaceutical Co., Ltd. and NIPRO Industry, and lecture fees from Kyowa Hakko Kirin Co., Ltd., Chugai Pharmaceutical Co., Ltd., Bayer Yakuhin, Ltd., Kissei Pharmaceutical Co., Ltd., Torii Pharmaceutical Co., Ltd. and Ono Pharmaceutical Co., Ltd. R.S. is employed by Kyowa Hakko Kirin Co., Ltd., which funded this research.